Stylianos Loukides

About Stylianos Loukides

Stylianos Loukides, With an exceptional h-index of 51 and a recent h-index of 28 (since 2020), a distinguished researcher at National and Kapodistrian University of Athens, specializes in the field of Medicine Respiratory.

His recent articles reflect a diverse array of research interests and contributions to the field:

Levels of Immunoglobulin E Sensitization Drive Symptom Thresholds in Allergic Rhinitis

Chest X-ray: Routine follow-up in community-acquired pneumonia?

Endotyping Eosinophilic Inflammation in COPD with ELAVL1, ZfP36 and HNRNPD mRNA Genes

Mortality prevention as the center of COPD management

Alpha1-antitrypsin deficiency in Greece: Focus on rare variants

COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study

Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk

Exploring Mechanisms in COPD: Time for Biomarker Reappraisal?

Stylianos Loukides Information

University

Position

Professor Medical School

Citations(all)

8814

Citations(since 2020)

3276

Cited By

6427

hIndex(all)

51

hIndex(since 2020)

28

i10Index(all)

126

i10Index(since 2020)

93

Email

University Profile Page

National and Kapodistrian University of Athens

Google Scholar

View Google Scholar Profile

Stylianos Loukides Skills & Research Interests

Medicine Respiratory

Top articles of Stylianos Loukides

Title

Journal

Author(s)

Publication Date

Levels of Immunoglobulin E Sensitization Drive Symptom Thresholds in Allergic Rhinitis

Annals of Allergy, Asthma & Immunology

Maria V Dimou

Paraskevi Xepapadaki

John Lakoumentas

Leonardos Mageiros

Xenophon Aggelidis

...

2024/4/26

Chest X-ray: Routine follow-up in community-acquired pneumonia?

Lung India

Vasileios Papavasileiou

Stelios Loukides

Ilektra Voulgareli

2024/3/1

Endotyping Eosinophilic Inflammation in COPD with ELAVL1, ZfP36 and HNRNPD mRNA Genes

Journal of Clinical Medicine

Ilektra Voulgareli

Maria Semitekolou

Ioannis Morianos

Myrto Blizou

Maria Sfika

...

2024/2/1

Mortality prevention as the center of COPD management

Andriana I Papaioannou

Georgios Hillas

Stelios Loukides

Theodoros Vassilakopoulos

2024/1/1

Alpha1-antitrypsin deficiency in Greece: Focus on rare variants

Pulmonology

SA Papiris

M Veith

AI Papaioannou

V Apollonatou

I Ferrarotti

...

2024/1/1

COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study

ERJ open research

Spyros A Papiris

Ilaria Campo

Francesca Mariani

Maria Kallieri

Lykourgos Kolilekas

...

2023/1/1

Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk

The Journal of Infectious Diseases

Dimitrios Paraskevis

Maria Gkova

Kassiani Mellou

Gerasimos Gerolymatos

Naya Psalida

...

2023/12/15

Exploring Mechanisms in COPD: Time for Biomarker Reappraisal?

Ilektra Voulgareli

Petros Bakakos

Stelios Loukides

2023/10/25

The clinical experience of patients with severe asthma and previous treatment with omalizumab, choosing mepolizumab in Greece.

Maria Kallieri

Andriana I Papaioannou

Eleftherios Zervas

Evangelia Fouka

Konstantinos Porpodis

...

2023/9/9

Global initiative for chronic obstructive lung disease (GOLD) recommendations: strengths and concerns for future needs

American journal of respiratory and critical care medicine

Alvar Agustí

Bartolome R Celli

Gerard J Criner

David Halpin

Antonio Anzueto

...

2023/4/1

Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study

Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology

Maria Kallieri

Andriana I Papaioannou

Eleftherios Zervas

Evangelia Fouka

Konstantinos Porpodis

...

2023/12/12

Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality

Journal of Clinical Medicine

Vagia Karageorgou

Andriana I Papaioannou

Maria Kallieri

Myrto Blizou

Stefanos Lampadakis

...

2023/9/11

New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis

Ilja Striz

Kornel Golebski

Zuzana Strizova

Stelios Loukides

Petros Bakakos

...

2023/5

Severe Asthma in the Era of Biologics: Continuous Challenges

Pinelopi Schoini

Petros Bakakos

Stelios Loukides

2023/6/5

547. Molnupiravir and Nirmatrelvir/Ritonavir Effectiveness in Reducing the Risk for COVID-19 Disease Progression and Death

Open Forum Infectious Diseases

Dimitrios Paraskevis

Mary Gkova

Kassiani Mellou

Kassiani Mellou

Kassiani Gkolfinopoulou

...

2023/12

Follow-up of patients with severe eosinophilic asthma receiving benralizumab for one year (gReek rEAl Life regIStry of benralizuMab: REALISM Study)

Chrysoula Kontogianni

Konstantinos Samitas

Petros Bakakos

Nikolleta Rovina

Stelios Loukides

...

2023/9/9

Eosinopenia as a prognostic biomarker for noninvasive ventilation use in COPD exacerbations

Journal of Personalized Medicine

Konstantinos Bartziokas

Evgenia Papathanasiou

Andriana I Papaioannou

Ilias Papanikolaou

Emmanouil Antonakis

...

2023/4/19

Defining response to therapy with biologics in severe asthma: from global evaluation to super response and remission

Andriana I Papaioannou

Evangelia Fouka

Konstantinos Bartziokas

Maria Kallieri

Angelos Vontetsianos

...

2023/6/3

The role of RNA binding proteins in eosinophilic COPD.

Ilektra Voulgareli

Maria Semitekolou

Ioannis Morianos

Myrto Blizou

Spyridon Papiris

...

2023/9/9

S50 Expression of IL-22 in tissue of early stage non-small cell lung cancer (NSCLC) patients with or without chronic obstructive pulmonary disease (COPD)

V Petta

I Vamvakaris

T Milas

E Theodorakis

M Tsatsis

...

2023/11/1

See List of Professors in Stylianos Loukides University(National and Kapodistrian University of Athens)